2009
DOI: 10.1248/bpb.32.2010
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacodynamic and Pharmacokinetic Evaluation of CS-526 in Cynomolgus Monkeys

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 35 publications
0
1
0
Order By: Relevance
“…(2), 3 PF-03716556 (3), 4 and soraprazan (BAY-359) (4) 5 ], pyrrolopyridazines (CS-526 (5) 6 ), and pyrrolopyiridines (6), 7,8,9 have been investigated as P-CABs (Fig. 1).…”
mentioning
confidence: 99%
“…(2), 3 PF-03716556 (3), 4 and soraprazan (BAY-359) (4) 5 ], pyrrolopyridazines (CS-526 (5) 6 ), and pyrrolopyiridines (6), 7,8,9 have been investigated as P-CABs (Fig. 1).…”
mentioning
confidence: 99%